Your browser doesn't support javascript.
The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID-19.
Liao, Mingfeng; Liao, Xuejiao; Yuan, Jing; Zhou, Bing; Liu, Yang; Jiang, Xiao; Zhang, Zhan; Guo, Caiping; Zhang, Yunjia; Zhang, Shuye; Liu, Lei; Zhang, Zheng.
  • Liao M; National Clinical Research Center for Infectious Disease, Institute for Hepatology, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
  • Liao X; National Clinical Research Center for Infectious Disease, Institute for Hepatology, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
  • Yuan J; Department for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
  • Zhou B; National Clinical Research Center for Infectious Disease, Institute for Hepatology, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
  • Liu Y; National Clinical Research Center for Infectious Disease, Institute for Hepatology, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
  • Jiang X; Department for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
  • Zhang Z; Guangdong Province Research & Development Centre of Protein (Peptide) Separation Engineering Technology, Shenzhen, China.
  • Guo C; Guangdong Province Research & Development Centre of Protein (Peptide) Separation Engineering Technology, Shenzhen, China.
  • Zhang Y; Guangdong Province Research & Development Centre of Protein (Peptide) Separation Engineering Technology, Shenzhen, China.
  • Zhang S; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Liu L; National Clinical Research Center for Infectious Disease, Institute for Hepatology, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
  • Zhang Z; Shenzhen Research Center for Communicable Disease Diagnosis and Treatment of Chinese Academy of Medical Science, Shenzhen, Guangdong Province, China.
Clin Transl Med ; 11(11): e571, 2021 11.
Article in English | MEDLINE | ID: covidwho-1499247
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Antibodies, Viral Type of study: Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Clin Transl Med Year: 2021 Document Type: Article Affiliation country: Ctm2.571

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Antibodies, Viral Type of study: Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Clin Transl Med Year: 2021 Document Type: Article Affiliation country: Ctm2.571